Market Overview - Stock futures are mixed, showing signs of stabilization after a downturn in software and AI-related technology stocks, leading some investors to view the selloff as a buying opportunity [1] - Defensive sectors and commodity-linked assets are gaining interest, particularly as gold prices have risen above $5,000 per ounce, indicating strong demand for safe havens amid market uncertainty [1] Pre-Market Trading - In pre-market trading, S&P 500 futures rose by 0.11%, Nasdaq futures fell by 0.34%, and Dow futures increased by 0.22% [2] Company Movements - Silicon Labs (SLAB) shares surged by 49% following a definitive agreement for acquisition by Texas Instruments (TXN) at $231 per share in an all-cash transaction [3] - Texas Instruments (TXN) shares declined by 3% after announcing the acquisition of Silicon Labs [6] - Other notable stock movements include Eli Lilly (LLY) up 9%, Johnson Controls (JCI) up 5%, and AMD (AMD) down 10% [6]

Group 1 - The service provided by Crude Value Insights focuses on oil and natural gas investments, emphasizing cash flow and companies that generate it, which leads to value and growth prospects with real potential [1] - Subscribers have access to a model account with over 50 stocks, in-depth cash flow analyses of exploration and production (E&P) firms, and live chat discussions about the sector [1] Group 2 - A two-week free trial is available for new subscribers, offering an opportunity to explore the oil and gas investment service [2]

GE HealthCare (NASDAQ:GEHC) on Wednesday reported adjusted earnings of $1.44 per share, beating the consensus of $1.40. • GE HealthCare Techs stock is showing exceptional strength. Why is GEHC stock surging?The global health care solutions provider reported sales of $5.69 billion, beating the consensus of $5.61 billion.Revenue growth of 7.1%, including organic revenue growth of 4.8%, was driven by Pharmaceutical Diagnostics (PDx), Imaging, and Advanced Visualization Solutions (AVS), with overall strength in ...

Key Takeaways GEHC beat Q4 EPS and revenue estimates, with 7.1% reported sales growth and a 1.06x book-to-bill.GEHC saw growth in Imaging, AVS and PDx, while Patient Care Solutions revenues fell year over year.Net income margin fell 320 bps from tariffs and mix, even as volume and pricing benefits aided.GE HealthCare (GEHC) reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.44, which beat the Zacks Consensus Estimate of $1.43 by 0.7%. However, the bottom line declined 0.7% year over year.G ...

As the only diagnostic imaging company with a full portfolio of contrast media and radiopharmaceuticals, we differentiate ourselves with our D3 strategy. We bring together smart devices and drugs across disease states enabled by digital AI and cloud to help support earlier, more accurate diagnosis and ultimately therapy delivery. Our three-year vitality rate for new products is strong at 55%, up approximately 5% from our prior year. Recall, this means 55% of our revenue is coming from new products. This rei ...

GE HealthCare Technologies (NasdaqGS:GEHC) Q4 2025 Earnings call February 04, 2026 08:30 AM ET Company ParticipantsAllen Gong - VP of Equity ResearchCarolynne Borders - Chief Investor Relations OfficerDavid Roman - Managing DirectorJay Saccaro - VP and CFOJoanne Wuensch - Managing DirectorMatthew Taylor - Managing DirectorPeter Arduini - President and CEOVijay Kumar - Senior Managing Director and Head of the Medical Supplies & Devices and Life Science Tools & Diagnostics TeamConference Call ParticipantsAnth ...

GE HealthCare Technologies (NasdaqGS:GEHC) Q4 2025 Earnings call February 04, 2026 08:30 AM ET Company ParticipantsCarolynne Borders - Chief Investor Relations OfficerDavid Roman - Managing DirectorJay Saccaro - VP and CFOJoanne Wuensch - Managing DirectorMatthew Taylor - Managing DirectorPeter Arduini - President and CEOVijay Kumar - Senior Managing Director and Head of the Medical Supplies & Devices and Life Science Tools & Diagnostics TeamConference Call ParticipantsAnthony Petrone - Managing Director an ...

GE HealthCare Technologies (NasdaqGS:GEHC) Q4 2025 Earnings call February 04, 2026 08:30 AM ET Speaker2Please know that today's conference is being recorded. I will now turn the call over to your speaker host for today, Carolyn Borders. Please go ahead.Speaker0Thanks, operator. Good morning, and welcome to GE HealthCare's fourth quarter and full year 2025 earnings call. I'm joined by our President and CEO, Peter Arduini, and Vice President and CFO, Jay Saccaro. Our conference call remarks will include both ...

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.45 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.00%. A quarter ago, it was expected that this medical technology company would post earnings of $1.05 per share when it actually produced earnings of $1.07, delivering a surprise of +1.9%.Over the las ...

4Q and Full Year 2025 Earnings Presentation February 4, 2026 © 2026 GE HealthCare. GE is a trademark of General Electric Company used under trademark license. Forward-looking statements and additional information This presentation contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as "will," "expect," "may," "would," "could," "plan," "believe," "anticipate," "intend," "estimate," "potential," "position," "forecast," "target," "gu ...